{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-019767","form_type":"8-K","ticker":"GNPX","cik":"0001595248","company_name":"Genprex, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.940725+00:00","generated_at":"2026-05-19T17:11:22.279287+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Genprex regains Nasdaq stockholders' equity compliance; bid price issue unresolved","bullets":["Received Nasdaq confirmation on June 6, 2025 that it regained compliance with stockholders' equity requirement of $2.5M.","Previously reported non-compliance with minimum bid price of $1.00 per share; compliance period ends August 6, 2025.","Company may consider reverse stock split or other options to regain bid price compliance; delisting risk remains."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-019767","json":"https://secwatch.observer/filing/0001437749-25-019767.json","markdown":"https://secwatch.observer/filing/0001437749-25-019767.md","text":"https://secwatch.observer/filing/0001437749-25-019767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925019767/0001437749-25-019767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925019767/gnpx20250606_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:11:22.279287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"290fcae59d3213a5e52785d5c7b8fa2b8ecd875c","claim":"Genprex, Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1), 5550(b)(2), 5550(b)(3)).","evidence_excerpt":"June 6, 2025, Genprex, Inc. (the “Company”) received a letter (the “June 2025 Compliance Letter”) from the Listing Qualifications Department (the “Nasdaq Staff”) of The Nasdaq Stock Market (“Nasdaq”) providing written confirmation that the Company has regained compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). The June 2025 Compliance Letter was pursuant to a previous letter received on November 19, 2024 (the “November 2024 Notice”) from the Nasd","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1595248/000143774925019767/0001437749-25-019767-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1), 5550(b)(2), 5550(b)(3)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}